Histological studies of organs in experiment on the application of a niosomal form of anti-tumor medicine
The study of histological changes showed that encapsulation of the antitumor substance N-hydroxy-2-(2-(naphthalen-2-yl)-1H-indol-3-yl)-2-phenylacetamide in niosomes increases its cytotoxicity. This is due to the peculiarities of the phar-macokinetics of niosomal drugs. When the antitumor substance i...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Статья |
| Iaith: | Russian |
| Cyhoeddwyd: |
Stavropol State Medical University
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://dspace.ncfu.ru/handle/20.500.12258/11613 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
| Crynodeb: | The study of histological changes showed that encapsulation of the antitumor substance N-hydroxy-2-(2-(naphthalen-2-yl)-1H-indol-3-yl)-2-phenylacetamide in niosomes increases its cytotoxicity. This is due to the peculiarities of the phar-macokinetics of niosomal drugs. When the antitumor substance is encapsulated in niosomes, its metabolism is slower in the liver, and due to this the substance is in the peripheral blood for a longer time at higher concentrations compared to the introduction of the antitumor substance in its pure form |
|---|